SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP HCV (AHCV) ASSAY; HEPATITIS C VIRUS (ANTI-HCV) ASSAY
|
Back to Search Results |
|
Model Number N/A |
Device Problems
Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 07/09/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
The cause for the discordant (b)(6) results is unknown.Siemens healthcare diagnostics has requested the patient samples for further testing and investigation.The ifu states in the limitations section: "a negative test result does not exclude the possibility of exposure to or infection with hcv.Hcv antibodies may be undetectable in some stages of the infection and in some clinical conditions." mdr 1219913-2018-00186, mdr 1219913-2018-00190, mdr 1219913-2018-00191, mdr 1219913-2018-00192, and mdr 1219913-2018-00193 were filed for the same event.
|
|
Event Description
|
Discordant (b)(6) results were obtained on samples from a known (b)(6) patient.The patient samples were tested on alternate method and the results were (b)(6).The pcr testing performed was (b)(6).The result from the (b)(6) testing was indeterminate.The previous results from 2013 to 2015 for the patient from alternate methods were (b)(6).Patient treatment was not altered or prescribed.There was no report of adverse health consequences due to the discordant (b)(6) result.
|
|
Manufacturer Narrative
|
Siemens filed the initial mdr 1219913-2018-00194 on (b)(6) 2018.Siemens filed the mdr 1219913-2018-00194 supplemental report 1 on (b)(6) 2018.On (b)(6) 2018 additional information: siemens has completed the testing and investigation into the discordant negative hcv patient sample.Testing on the inno-lia demonstrated a negative hcv score with all antigen bands showing a negative reactivity.The patient sample was then tested on the advia centaur xp with ahcv lot 294 (available lot) using antigen specific solid phases.The solid phases tested were control (standard readypack), c22, c200, and ns5 wetcakes.The patient sample showed similar recovery to a pool of 20 hcv negative patients.The testing showed negative inno-lia hcv score, negative reactivity to ahcv lot 294 reagent on the advia centaur xp, and no reactivity to antigen specific wetcakes.This could be a case of an initial false positive on the alternate, initial testing platform.The cause for the discordant hcv results is unknown.The instrument is performing within specifications.No further evaluation of the device is required.Mdr 1219913-2018-00186 supplemental report 2, mdr 1219913-2018-00190 supplemental report 2, mdr 1219913-2018-00191 supplemental report 2, mdr 1219913-2018-00192 supplemental report 2, and mdr 1219913-2018-00193 supplemental report 2 were filed for the same event.
|
|
Manufacturer Narrative
|
Siemens filed the initial mdr on july 18, 2018.08/03/2018 additional information: the customer's decision was to report the final result as positive based on historical data and the result of elisa kit hcv murex that is used as confirmation.The patient sample was received for further testing and investigation at the manufacturer's site.Mdr 1219913-2018-00186 supplemental report 1, mdr 1219913-2018-00190 supplemental report 1, mdr 1219913-2018-00191 supplemental report 1, mdr 1219913-2018-00192 supplemental report 1, and mdr 1219913-2018-00193 supplemental report 1 were filed for the same event.
|
|
Search Alerts/Recalls
|
|
|